ARCHIVES

Broder Explains Where R01 Money Has Gone

This article is from The Cancer Letter archive.

Vol. 16 No. 29 | July 20, 1990

Download PDF Visit The Full Archive

Related Articles

ODAC To Advise FDA on First Biosimilars Application Jan. 7

December 19, 2014

FDA To Issue “Complete Response” Letters To Drug Sponsors.

July 11, 2008

Five Contracts Funded Under Unconventional Innovations Program

October 22, 1999

Duke Comprehensive Cancer Center Wins Core Grant Renewal

September 17, 2010

Rauscher Summarizes Criticism of Cooperative Groups; Changes To Await May 22024 Conference

May 9, 1975

NRC Group Splits Over chemical Dose Testing For Carcinogenicity

March 12, 1993